Advances in Economics, Management and Political Sciences

- The Open Access Proceedings Series for Conferences


Proceedings of the 2nd International Conference on Financial Technology and Business Analysis

Series Vol. 54 , 01 December 2023


Open Access | Article

Financial Analysis of the Pharmaceutical Industry Based on Dupont Analysis: Taking Guangzhou Baiyunshan Pharmaceutical Group as an Example

Yantong Jiang * 1
1 Zhuhai College of Jilin University

* Author to whom correspondence should be addressed.

Advances in Economics, Management and Political Sciences, Vol. 54, 40-48
Published 01 December 2023. © 2023 The Author(s). Published by EWA Publishing
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation Yantong Jiang. Financial Analysis of the Pharmaceutical Industry Based on Dupont Analysis: Taking Guangzhou Baiyunshan Pharmaceutical Group as an Example. AEMPS (2023) Vol. 54: 40-48. DOI: 10.54254/2754-1169/54/20230874.

Abstract

As an “infrastructure industry”, the pharmaceutical industry is related to people’s livelihood and social stability and is one of the pillar industries of society. With the in-depth advancement of various medical policy reforms since 2021, the scale of China’s pharmaceutical market has continued to rise, and the revenue and profit of the pharmaceutical industry have maintained steady growth, so the industry still has outstanding growth advantages. Based on the pharmaceutical industry, this paper selects Guangzhou Baiyunshan Pharmaceutical Group as the research object, takes the company’s financial data from 2018 to 2022 as the basis, conducts a comprehensive study on the company’s operating conditions based on DuPont analysis, and finds that Guangzhou Baiyunshan has problems such as high financial risk, low turnover of receivables and low profitability during its development. The paper puts forward the corresponding suggestions of saving expenditure, increasing income and focusing on sustainable development in solvency; improving enterprise credit policy and strengthening accounts receivable management in operational capacity; and optimizing pharmaceutical R&D investment and management in profitability.

Keywords

pharmaceutical industry, Guangzhou Baiyunshan, DuPont analysis, financial analysis, return on net assets

References

1. Liu, Ruijie. (2022). Asset quality analysis and evaluation of Guangzhou Baiyunshan Pharmaceutical Group Co. Investment and cooperation. (06),127-129.

2. Liu Haiyue. (2022). Research on Financial Strategy of Guangzhou Baiyunshan Pharmaceutical Group (Master’s thesis, Harbin University of Commerce).

3. Samuel Jebaraj Benjamin, Zulkifflee Bin Mohamed & M. Srikamaladevi Marathamuthu .(2018). DuPont analysis and dividend policy: empirical evidence from Malaysia. Pacific Accounting Review(1).

4. Asher Curtis,Melissa F. Lewis-Western & Sara Toynbee. (2015). Historical cost measurement and the use of DuPont analysis by market participants. Review of Accounting Studies(3). doi:10.1007/s11142-015-9334-y.

5. He Yu. (2023). Corporate Profitability Analysis Based on DuPont Analysis--Taking Xiaomi as an Example. China Township Enterprises Accounting (08), 58-60.

6. Wen Chen. (2022). Research on Financial Performance Evaluation of Yutong Bus (Master’s thesis, Northeast Petroleum University).

7. Guangzhou Baiyunshan Pharmaceutical Group 2022 Annual Financial Report. 2023. National Enterprise Credit Information Publication System.https://shiming.gsxt.gov.cn/socialuser-use-rllogin.html。

8. Eastmoney. 2023. https://www.eastmoney.com/

9. Marianna Botika. (2012). The use of DuPont Analysis in Abnormal Returns Evaluation: Empirical Study of Romanian Market. Procedia - Social and Behavioral Sciences(C). doi:10.1016/j.sbspro.2012.09.202.

10. Gao Yalin. (2022). A study on profitability based on DuPont analysis--Taking China Resources Sanjiu as an example. Financial Tribune (06), 22-24.

11. Zhang, Ziyu. (2023). Analysis of financial performance of Xiaomi under asset-light operation. CO-Oerativeconomy & Science (19), 150-154. doi:10.13665/j.cnki.hzjjykj.2023.19.049.

Data Availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).

Volume Title
Proceedings of the 2nd International Conference on Financial Technology and Business Analysis
ISBN (Print)
978-1-83558-155-1
ISBN (Online)
978-1-83558-156-8
Published Date
01 December 2023
Series
Advances in Economics, Management and Political Sciences
ISSN (Print)
2754-1169
ISSN (Online)
2754-1177
DOI
10.54254/2754-1169/54/20230874
Copyright
01 December 2023
Open Access
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Copyright © 2023 EWA Publishing. Unless Otherwise Stated